๐ŸŽ™๏ธ๐Ÿ”™ ๐“๐ก๐ซ๐จ๐ฐ๐›๐š๐œ๐ค ๐ญ๐จ ๐จ๐ง๐ž ๐จ๐Ÿ ๐ฅ๐š๐ฌ๐ญ ๐ฒ๐ž๐š๐ซ'๐ฌ ๐ก๐จ๐ญ๐ญ๐ž๐ฌ๐ญ ๐ญ๐ซ๐ข๐š๐ฅ ๐๐ข๐ฌ๐œ๐ฎ๐ฌ๐ฌ๐ข๐จ๐ง๐ฌ: SURPASS-CVOT (tirzepatide vs dulaglutide on MACE in #T2D + ASCVD). Missed it? Catch up now ๐Ÿ‘‡ Back at #EASD2026 too: ๐Ÿ“… Wed, 30 Sep 2026 | ๐Ÿ•— 08:30 - 09:30 |๐Ÿ“ Dublin Hall ๐ŸŽง Listen here: diabetes-insights.podigee.io/47-surpass-c...

0 comments โ€” live from bluesky

No comments yet.